Forthcoming Issue

Feature: Article(s)

Modeling and Simulation Guides Crucial Decision Making During COVID-19 Pandemic

Thomas Kerbusch, Chief Growth Officer, Certara

Artificial intelligence in clinical practice

Josep M Guiu-Segura, Head, Pharmacotherapy, Catalan Health and Social Care Consortium

Integrated Continuous Biomanufacturing

Anurag Rathore, Professor, Department of Chemical Engineering, Indian Institute of Technology

A Decade of Reinforcing Business Integrity has Better Prepared the Asia-Pacific for COVID-19

Thomas Cueni, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA); Director General and Co-Chair, APEC Biopharmaceutical Working Group on Ethics

The Digitalization of crystallization process: a holistic control strategy in pharma 4.0

Kirankumar Ramisetty, Research Fellow, Innopharma Technology

Patient-centric' clinical trials - how language and tech are re-shaping clinical trials today

Nimita Limaye, SVP, Strategic Partnerships and Medical Writing, SVP, CSOFT Health Sciences

Double-blinding Capsules for Clinical trials and how Over-encapsulation can help tackle bias

Julien Lamps, Product Manager, Capsules and Health Ingredients, Lonza

AI in Drug Discovery

Dhruv Kumar, Associate Professor, Amity Institute of Molecular Medicine & Stem Cell Research

Regulations to enable Safe, Effective & high-Quality AI/ML/Digital solutions in Drug Development

Shrishaila Patil, Vice President, Statistical Programming, Navitas Data Sciences, a part of Navitas Life Sciences (a TAKE Solutions Enterprise)

COVID 19 Pandemic - Impact on Pharma Industry

Aditya, Principal, Roland Berger

Pharma Logistics